Skip to main content

stock

YBGJ · Yubo International Biotech Ltd

What Yubo International Biotech Ltd reports to the SEC, read from its filings.

Open in the app

Price

The live YBGJ price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on YBGJ.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
170,416,343 as of 2026-03-25 (XBRL frame CY2026Q1I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
66.1%
Operating
-8085.7%
Net
-7559.6%

Returns

ROE
—
ROA
-138.9%

Health

Current ratio
0.2x
Debt/equity
—

Deep value

NCAV
-$2.74M
NCAV per share
-$0.02
Price/NCAV
Locked
NNWC
-$3.30M
NNWC per share
-$0.02
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30$0$0-$238,860-$247,949
10-Q filed 2026-08-14
2026-03-31$0$0-$289,274-$272,608
10-Q filed 2026-05-15
2025-12-31$12,353$8,165-$160,564-$103,133
10-K filed 2026-03-31
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30$0$0-$310,134-$310,152
10-Q filed 2025-11-14
2025-06-30$0$0-$249,699-$230,333
10-Q filed 2026-08-14
2025-03-31$0$0-$467,299-$435,630
10-Q filed 2026-05-15
2024-12-31-$18-$13-$357,298-$249,789
10-K filed 2026-03-31
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30$0$0-$532,764-$621,053
10-Q filed 2025-11-14
Assets
$672,272
Equity
-$2.62M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$12,353-$1.19M-$1.08M—
2024-12-31$3,470-$1.77M-$1.78M—
2023-12-31$604,676-$1.19M-$1.20M—
2022-12-31$104,283-$1.21M-$1.20M-$600,953
2021-12-31$1.24M-$1.54M-$1.54M-$1.59M
2020-12-31—-$711,798-$711,801$58,551
2020-02-29$0-$29,000-$134,000—
2019-02-28$0-$48,000-$148,000—
2018-02-28$0-$58,000-$144,000—
2017-02-28$0-$149,000-$224,000—

Company filings

events

  • Auditor change

    Auditor change
    Jan 168-K

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named YBGJ, and the market events around them.

Sign in to see this

Board

The YBGJ board could not be loaded.

Retry the YBGJ board

nakagai

Signals on YBGJ come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the YBGJ board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Yubo International Biotech Ltd (YBGJ): SEC filings, financials and insider trades · Nakagai